Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefapixant in Endometriosis-Related Pain
NCT03654326Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Sep 2018
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 9
01
Overview
Phase 2, randomised, double-blind trial in endometriosis comparing Gefapixant with Placebo (2 arms). Primary endpoint: Average Daily Pelvic Pain Score. Started Sep 2018; status: completed.
02
Drugs
gefapixant
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT03654326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03654326.